GxP Lifeline Medical Device Publication Click to visit GxP Lifeline Home Click to visit mastercontrol.com

Featured Articles

January 2012

Holly Scott

What to Expect When They're Inspecting - Part II

by Holly Scott
Biologics Consulting Group, Senior Consultant and Former CBER Consumer Safety Officer and FDA Field Investigator

The first segment of this series focused on some of the non-traditional variables that can have an effect on any FDA inspection and how to achieve a positive outcome regardless of the inspectional conclusion. That article generated some blog discussion on FDA's objectivity. I wanted to clarify some of those issues. FDA investigators are trained to be objective in all situations and will approach their inspection in this manner. However, firm management needs to understand that when intentional barriers to an effective inspection are presented or the FDA investigator is met with a less-than-cooperative attitude, the realistic conclusion is that management is trying to hide objectionable GMP conditions, leaving the Investigator no choice but to be even more thorough to ensure there are no safety or quality risks to the consumer. It isn't that an FDA investigator is showing bias or being subjective, they're "Investigators" - it's their job to do so.

Read more

Martin Browning

Annex 11: The EU's New Expectations for Regulated Computerized Systems

by Martin Browning
President and Co-Founder, EduQuest

In 2011, the European Union (EU) revised its guidance for the lifecycle of computerized systems to reflect the increased use and complexity of automated systems in the pharmaceutical industry. The guidance, called Annex 11, also was revised in response to an alarming number of problems detected in computerized systems.

In plain English, Annex 11 wants to ensure the computerized systems you use to manufacture medicinal products have no adverse impact on product quality, product efficacy, or patient safety. In addition, when a computerized system replaces a manual operation, Annex 11 wants to ensure there are no increased risks.

Read more

MasterControl Presents 'Change Control--a Risk-Based Approach' at MD&M Texas

MasterControl, Inc. will present "Change Control--a Risk-Based Approach" as a workshop at the MD&M Texas 2012 Conference, March 15, 2012 at the Fort Worth Convention Center in Fort Worth, Texas. MasterControl's Kevin Marcus, product manager and medical device expert, and Walt Murray, director of quality and compliance services, will conduct the workshop.

Read more


Featured Webinar:

Featured White Paper:

Previous Newsletters:

Watch Customer Videos

View Upcoming Events

Did You Know?

MD&M West
February 14-16, 2012, Anaheim, CA

MD&M East
May 21-24, 2012, Philadelphia, PA

View More Events

"Trevor Baumel, manager of supply chain management for Celestica HealthTech, Zurich, discussed the future of healthcare supply chains and leveraging the power of supply chain leaders during Compamed 2011, a three-day exhibition (Nov. 16-18) geared for medical manufacturing contractors in Düsseldorf, Germnay. He shared some of his wisdom about global supply chain management and the changes that have occurred in the international market..."
Read More